The Effect of Ocrelizumab in the Treatment of Multipl Sclerosis
Journal Title: UNKNOWN - Year 2017, Vol 23, Issue 3
Abstract
.
Authors and Affiliations
Şenay Yıldız Çelik
Keywords
Related Articles
- EP ID EP276706
- DOI 10.4274/tnd.71354
- Views 76
- Downloads 0
Mortality in Patients with Multiple Sclerosis
.
Weight Loss and Fingolimod
.
Postmenopausal Female with Unilateral Involuntary Movements
.
Medusa-like Atypical Intracerebral Vein: A Rare Case of Symptomatic Developmental Venous Anomaly
Developmental venous anomaly (DVA) is an extreme variation of the normal transmedullary vein, which is necessary for the normal venous drainage of an area of the brain. It occurs in as many as 2% of individuals. In most...
Assessment of Trunk Control in Patients with Neuromuscular Diseases: Validity and Reliability of the Trunk Impairment Scale
Objective: The aim of our study was to determine the reliability and validity of the Trunk Impairment Scale (TIS) in patients with adult neuromuscular diseases (NMD). Materials and Methods: Sixty-six patients with NMD pa...